title: [Effect of capsule yindanxinnaotong (YD) on blood hemorheology and the score of blood stasis in patients with MS complicated ACS].
abstract: OBJECTIVE
  To observe the effect of Capsule YD on blood hemorheology and the score of blood stasis in patients with MS complicated ACS, and to investigate the clinical effect of Chinese medicine of promoting blood flow on those diseases.
  
  
  METHODS
  63 cases were divided into two groups. Control group was treated with routine methods and YD group with additional YD. The course of treatment was 3 months. Blood hemorheology and the score of blood stasis were observed.
  
  
  RESULTS
  Blood viscosity high shear rate, fibrinogen, the index and deformed index of Erythrocyte aggregation before and after treatment in both groups were improved (P < 0.05). And the index of Erythrocyte aggregation in YD group was significantly improved comparing to that in control group (P < 0.05). The symtom of stethalgia, frequency of episode, and blood stasis on tongue, lip and gums were also improved in YD group. The value of blood stasis in YD group was significantly decreased comparing to that in control group.
  
  
  CONCLUSIONS
  Capsule YD can improve the angina pectoris and decrease the value of blood stasis in patients with ACS, and also improve their hemorheology. We should presume the Chinese medicine of activating blood circulation to dissipate blood stasis improve the metabolism and treat angina pectoris by improving blood hyperviscosity.
authors.affiliation: Department of Traditional Chinese Medicine, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Meng
authors.forename: Jian
authors.initials: J
authors.lastname: Qin
authors.forename: Ming-hua
authors.initials: MH
authors.lastname: Jin
authors.forename: Rui-xiang
authors.initials: RX
authors.lastname: Qiu
mesh_terms: D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects*; D002214:Capsules; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D004903:Erythrocyte Aggregation / Q000187:drug effects; D004907:Erythrocyte Deformability / Q000187:drug effects; D005260:Female; D018056:Hemorheology; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000737:chemistry; D016896:Treatment Outcome
chemical_list: D002214:Capsules; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal